agilon health inc
NYSE:AGL
agilon health inc
Cash & Cash Equivalents
agilon health inc
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
agilon health inc
NYSE:AGL
|
Cash & Cash Equivalents
$107.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash & Cash Equivalents
$380.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$686m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
38%
|
CAGR 10-Years
14%
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$8.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$7.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$536.8m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
See Also
What is agilon health inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
107.6m
USD
Based on the financial report for Dec 31, 2023, agilon health inc's Cash & Cash Equivalents amounts to 107.6m USD.
What is agilon health inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
0%
Over the last year, the Cash & Cash Equivalents growth was -78%.